Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutideglp-1 receptor agonistssedationgastric emptying

Dental anesthesia journal flags GLP-1 agonists as preoperative blind spot

Japanese authors argue sedation teams may not be asking about incretin use despite delayed gastric emptying and aspiration concerns.

MH
By Maren Holt · Senior Reporter, GLP-1

The wire

  1. 01A commentary in the Journal of Dental Anesthesia and Pain Medicine identifies GLP-1 receptor agonist use as a gap in routine preoperative assessment for dental sedation.
  2. 02Dental and office-based sedation providers see patients who may not volunteer incretin use, making medication history and fasting guidance a practical screening issue.
  3. 03The piece is a perspective in a specialty journal rather than a guideline or outcomes study; it does not establish event rates in dental sedation.

From the source

GLP-1 receptor agonists and dental sedation: a potential blind spot in preoperative assessment

Journal of dental anesthesia and pain medicine · 2026 Oct · Yamamoto T, Kishimoto N et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →